期刊文献+

沉默中介体复合物亚基19基因对人膀胱癌细胞UM-UC3迁移能力的影响

Lentivirus-mediated inhibition of Med19 suppresses migration of bladder cancer UM-UC3 cells
下载PDF
导出
摘要 目的探讨中介体复合物亚基19(Med19)对人膀胱癌UM-UC3细胞迁移能力的影响及其机制。方法采用针对Med19的siRNA慢病毒载体转染人膀胱癌UM-UC3,应用实时荧光定量PCR(qRT-PCR)和蛋白质印迹方法(Western blot)检测Med19-siRNA转染组(siRNA)与空载组(NC)Medl9基因表达情况;采用Western blot检测细胞外基质金属蛋白酶(MMP)-2和MMP-9的表达;采用划痕实验和Transwell实验检测细胞迁移能力的变化。结果 Medl9-siRNA慢病毒感染UM-UC3细胞后,转染组Medl9mRNA表达与空载组相比明显降低,差异有统计学意义(t=10.15,P<0.01),且转染组Med19、MMP-2和MMP-9蛋白表达明显降低,差异有统计学意义(t值分别为71.36,26.34,8.627,均P<0.01),划痕实验和Transwell实验显示转染组细胞迁移能力明显减弱。结论沉默Med19基因可通过抑制MMP-2和MMP-9的表达降低人膀胱癌细胞UM-UC3的迁移能力。 Objective To study the effect of lentivirus-mediated inhibition of Med19 on the migration of human bladder cancer UM-UC3 cells,and to explore its potential mechanism.Methods The lentivirus vectors containing small interfering RNA(siRNA)targeting Medl9 gene were constructed and transfected to human bladder cancer UM-UC3 cells.Quantitative real-time PCR(qRT-PCR)and Western blot analysis were used to detect the Medl9 expression in the siRNA group(LvMed19siRNA cells)and the NC group(Lv-NC-infected cells)72 h after the transfection.Western blot was used to examine the changes of expression in matrix metalloproteinase 2(MMP-2)and MMP-9.The influence of Medl9 on the migration of bladder cancer cell was assessed with wound healing assay and transwell assay.Results The expressions of MMP-2 and MMP-9 were greatly reduced72 h after Med19inhibition(t value was 26.34 and8.627,P〈0.01),and the migration ability was remarkably inhibited in the siRNA group.Conclusion Med19 inhibition reduces migration ability of human bladder cancer UM-UC3 cells via down-regulating MMP-2 and MMP-9 expressions.
出处 《现代泌尿外科杂志》 CAS 2016年第2期147-149,共3页 Journal of Modern Urology
基金 山东省自然科学基金英才基金资助项目(No.ZR2015HM021)
关键词 MED19 慢病毒 RNA干扰 膀胱癌 迁移 Med19 bladder cancer migration
  • 相关文献

参考文献4

二级参考文献86

  • 1蔡敏,钱军程,Jun-cheng.中国女性吸烟流行趋势及影响因素分析[J].中国医院统计,2009(4). 被引量:14
  • 2Okuda K. Natural history of hepatocellular carcinoma including fibrolamellar and hepato-cholangio carcinoma variants. J Gastroenterol Hepatol 2002; 17: 401-5.
  • 3Bosch FX, Ribes J, Cleries R, Diaz M. Epidemiology of hepatocellular carcinoma. Clin Liver Dis 2005; 9: 191-211.
  • 4EI-Serag HB. Hepatocellular carcinoma: Recent trends in the United States. Gastroenterology 2004; 127:S27-34.
  • 5McKillop IH, Schrum LW. Alcohol and liver cancer. Alcohol 2005; 35: 195-203.
  • 6Farazi PA, De Pinho RA. Hepatocellular carcinoma pathogenesis: from genes to environment. Nat Rev Cancer 2006; 6: 674-87.
  • 7EIbashir SM, Harborth J, Lendeckel W, Yalcin A, Weber K, Tuschl T. Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells. Nature 2001; 411: 494-8.
  • 8Fidler U. The pathogenesis of cancer metastasis: the 'seed and soil' hypothesis revisited. Nature Rev Cancer 2003; 3: 453-8.
  • 9Westhof E, Filipowicz W. From RNAi to epigenomes: how RNA rules the world. Chem Biochem 2005; 6: 441-3.
  • 10Sato S, Tomomori-Sato C, Parmely TJ, Florens L, Zybailov B, Swanson SK, et al. A set of consensus mammalian mediator subunits identified by multidimensional protein identification technology. Mol Cell 2004; 14: 685-91.

共引文献88

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部